Soluble VCAM-1 binding to α4 integrins is cell-type specific and activation dependent and is disrupted during apoptosis in T cells

Blood

Volumn 95, Issue 2, 2000, Pages 602-609

  Rose, David M ^a   Cardarelli, Pina M ^b   Cobb, Ronald R ^b   Ginsberg, Mark H ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b Tanabe Research Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULAR CELL ADHESION MOLECULE 1;

APOPTOSIS; ARTICLE; BINDING AFFINITY; CELL ACTIVATION; CELL SPECIFICITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; LIGAND BINDING; LYMPHOCYTE FUNCTION; PRIORITY JOURNAL; PROTEIN BINDING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 0034651015     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Hemler ME. VLA proteins in the integrin family: structures, (unctions, and their role on leukocytes. Annu Rev Immunol. 1990:8:365-400.
2. 2~. Osbom L, Hession C, Tizard R, et al. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell. 1989;59:1203-1211.
3. Salomon D, Crisa L, Mojcik CF, Ishii JK, Klier FG, Shevach EM. Vascular cell adhesion molecule-1 is expressed by cortical thymic epithelial cells and mediates thymocyte adhesion: implications for function VLA4 integrin in T-cell development. Blood. 1997:89:2461-2471.
4. Alon R, Kassner PD, Carr MW, Finger EB, Hemler M, Springer TA. The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J Cell Biol. 1995:127:1485-1495.
5. Arroyo AG, Yang JT, Raybum H, Hynes RO. Differential requirements for a4 integrins in hematopoiesis. Cell. 1996:85:997-1008.
6. Pigott R, Dillon LP, Hemingway I, Gearing AJH. Soluble forms of E-selectin, ICAM-1, and VCAM-1 are present in the supernatant of cytokine activated culture endothelial cells. Biochem Biophys Res Comm. 1992:187:584-589.
7. Wellicome SM, Kapahi P. Mason JC, Lebranchu Y, Yarwood H, Haskard DO. Detection of a circulating form of vascular cell adhesion molecule-1 : raised levels in rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Immunol. 1993; 92:412-418.
8. Leca G, Mansur SE, Bensussan A. Expression of VCAM-1 (CD106) by a subset of TCR-gd-bearing lymphocyte clones: involvement of a metalloprotease in the specific hydrolytic release of the soluble isoform. J Immunol. 195:154:1069-1077.
9. Kitani A, Nakashima N, Izumihara T, et al. Soluble VCAM-1 induces chemotaxis of jurkat and synovial fluid cells bearing high affinity very late antigen-4. J Immunol. 1998:161:4931-4938.
10. Kitani A, Nakashima N, Matsuda T, et al. T cells bound by vascular cell adhesion molecule-1/ CD106 in synovial fluid in rheumatoid arthritis: inhibitory role of soluble vascular cell adhesion molecule-1 in T-cell activation. J Immunol. 1996; 156:2300-2308.
11. Hughes PE, Pfaff M. Integrin affinity modulation. Trends Cell Biol. 1998:8:359-364.
12. Schwartz MA, Schaller MD, Ginsberg MH. Integrins: emerging paradigms of signal transduction. Ann Rev Cell Dev Biol. 1995:11:549-599.
13. Bazzoni G, Hemler ME. Are changes in integrin affinity and conformation overemphasized? Trends Biochem Sei. 1998:23:30-34.
14. Kucik DF, Dustin ML, Miller JM, Brown EJ. Adhesion-activating phorbol esters increase the mobility of leukocyte integrin LFA-1 in cultured lymphocytes. J Clin Invest. 1996:97:2139-2144.
15. Stewart M, Hogg N. Regulation of leukocyte integrin function: affinity vs. avidity. J Cell Biochem. 1996:61:554-561.
16. , 16. Altieri DC, Bader R, Mannucci PM, Edgington TS. Oligospecificity of the cellular adhesion receptor MAC-1 encompasses an inducible recognition specificity for fibrinogen. J Cell Biol. 1988;107: 1893-1900.
17. Faull RJ, Kovach NL, Harlen JM, Ginsberg MH. Stimulation of integrin-mediated adhesion of T lymphocytes and monocytes: two mechanisms with divergent biological consequences. J Exp Med. 1994:179:1307-1316.
18. Jâkubôwski A, RosaMD, BixlerS, LobbR, Burkly LC. Vascular cell adhesion molecule (VCAM)-lg fusion protein defines distinct affinity states of the very late antlgen-4 (VLA-4) receptor. Cell Adhes Commun. 1995:3:131-142.
19. Giblin PA, Hwang ST, Katsumoto TR, Rosen SD. Ligation of L-selectin on T lymphocytes activates betal integrins and promotes adhesion to fibronectin. J Immunol. 1997:159:3493-3507.
20. YednockTA, Cannon C, Vandevert C, et al. a4, integrin-dependent cell adhesion is regulated by a low affinity receptor pool that is conformationally responsive to ligand. J Biol Chem. 1995;270: 28,740-28,750.
21. Puzon-McLaughlin W, Yednock TA, Takada Y. Regulation of conformation and ligand binding function of alphaSbeta! by the betal cytoplasmic domain. J Biol Chem. 1996:271:16,580-16,585.
22. Kamata T, Puzon W, Takada Y. Identification of putative ligand-binding sites of the integrin a41 (VLA-4, CD49d/CD29). Biochem J. 1995:305: 945-951.
23. LaFlamme SE, Akiyama SK, Yamada KM. Regulation of fibronectin receptor distribution. J Cell Biol. 1992:117:437-447.
24. Bolder JT, Heidecker G, Rapp UR. Serum-, TPA-, and ras-induced expression from AP-1/Ets-driven promoters requires Raf-1 kinase. Genes Dev. 1992:545-556.
25. Hughes PE, Renshaw MW, Pfaff M, et al. Suppression of integrin activation: a novel function of a Ras/Raf-initiated MAP kinase pathway. Cell. 1997;88:521-530.
26. Schoen RC, Bentley KL, Klebe RJ. Monoclonal antibody against human fibronectin which inhibits cell attachment. Hybridoma. 1982:1:99-108.
27. Bowditch RD, Halloran CE, Aota S, et al. Integriniibps (platelet GPIIb-llla) recognizes multiple sites in fibronectin. J Biol Chem. 1991;266: 23,323-23,328.
28. Sanchez-Aparicio P, Dominguez-Jimenez C, Garcia-Pardo A. Activation of the cui integrin through the b, subunit induces recognition of the RODS sequence in fibronectin. J Cell Biol. 1994; 126:271-279.
29. Fenczik CA, Sethi T, Ramos JW, Hughes PE, Ginsberg MH. Complementation of dominant suppression implicates CD98 in integrin activation. Nature. 1997:370:81-5.
30. Osbom L, Vassallo C, Browning BG, et al. Arrangement of domains, and amino acid residues required for binding of vascular cell adhesion molecule-1 to its counter-receptor VLA-4(a41). J Cell Biol. 1994:124:601-608.
31. Hession C, Tizard R, Vassalio C, et al. Cloning of an alternate form of vascular cell adhesion molecule-1 (VCAM1). J Biol Chem. 1991:266:66826685.
32. Kassner PD, Alon R, Springer TA, Hemler M. Specialized functional properties of the integrin alpha4 cytoplasmic domain. Mol Biol Cell. 1995; 6:661-674.
33. Weitzman JB, Pujades C, Hemler ME. Integrin alpha chain cytoplasmic tails regulate "antibodyredirected" cell adhesion, independently of ligand binding. Eur J Immunol. 1997;27:78-84.
34. Yauch RL, Felsenfeld DP, Kraeft SK, Chen LB, Sheetz MP, Hemler ME. Mutational evidence for control of cell adhesion through integrin diffusion/ clustering, independent of ligand binding. J Exp Med1997;186:1347-1355.
35. Faull RJ, Kovach NL, Harten JM, Ginsberg MH. Affinity modulation of integrin as$-i: regulation of the functional response by soluble fibronectin. J Cell Biol. 1993;121:155-162.
36. Trinchieri G. Biology of natural killer cells. Adv Immunol. 1990;47:187-376.
37. Timonen T. Natural killer cells: endothelial interactions, migration, and target cell recognition. J LeukocBiol. 1997;62:693-701.
38. Palecek SP, Loftus JC, Ginsberg MH, Horwitz AF, Lauffenburger DA. Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness. Nature. 1997;385:537540.
39. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994;76:301-314.
40. Bradley LM, Watson SR. Lymphocyte migration into tissue: the paradigm derived from CD4 subsets. CurrOpin Immunol. 1996;8:312-320.
41. Salomon DR, Mojcik CF, Chang AC, et al. Constitutive activation of integrin a4i defines a unique stage of human thymocyte development. J Exp Med. 1994:179:1573-1584.
42. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26: 239-257.
43. Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol. 1980;68: 251-306.
44. Martin SJ, O'Brien GA, Nishioka WK, et al. Proteolysis of fodrin (non-erythroid) during apoptosis. J Biol Chem. 1995:270:6425-6428.
45. Brancolini C, Lazarevic D, Rodriquez J,
46. Schneidner C. Dismantling cell-cell contact during apoptosis is coupled to caspase-dependent proteolytic cleavage of catenin. J Ceil Biol. 1997; 139:759-771.
47. Wen L-P, Fahrni JA, Troie S, Guan J-L, Orth K, Rosen GD. Cleavage of focal adhesion kinase by caspases during apoptosis. J Biol Chem. 1997; 272:26,056-26,061.
48. Widmann C, Gibson S, Johnson G. Caspasedependent cleavage of signaling proteins during apoptosis: a turn-off mechanism for anti-apoptotic signals. J Biol Chem. 1998:273:7141-7147.
49. Meredith JE Jr, Mu Z, Saido T, Du X. Cleavage of the cytoplasmic domain of the integrin betas subunit during endothelial cell apoptosis. J Biol Chem. 1998:273:19,525-19,531.
50. Shattil SJ, O'Toole TE, Eigenthaler M, et al. 3 endonexin, a novel polypeptide that interacts specifically with the cytoplasmic tail of the integrin 3 subunit. J Cell Biol. 1995:131:807-816.